Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Accuracy, Conclusions, and Reporting Completeness With Acceptance by Radiology Conferences and Journals.
Frank RA, Fabiano N, Hallgrimson Z, Korevaar DA, Cohen JF, Bossuyt PM, Leeflang MMG, Moher D, McInnes MDF; UnBIAS Research Group; Treanor L, Salameh JP, McGrath TA, Sharifabadi AD, Atyani A, Kazi S, Choo-Foo J, Asraoui N, Alabousi M, Ha W, Prager R, Rooprai P, Pozdnyakov A, John S, Osman H, Islam N, Li N, Gauthier ID, Absi M, Kraaijpoel N, Ebrahimzadeh S, Port JD, Stoker J, Klein JS, Schweitzer M. Frank RA, et al. Among authors: gauthier id. J Magn Reson Imaging. 2022 Aug;56(2):380-390. doi: 10.1002/jmri.28046. Epub 2022 Jan 8. J Magn Reson Imaging. 2022. PMID: 34997786
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
Goss G, Shepherd FA, Laurie S, Gauthier I, Leighl N, Chen E, Feld R, Powers J, Seymour L. Goss G, et al. Eur J Cancer. 2009 Mar;45(5):782-8. doi: 10.1016/j.ejca.2008.10.022. Epub 2008 Dec 16. Eur J Cancer. 2009. PMID: 19091548 Clinical Trial.
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials group.
Laurie SA, Gauthier I, Arnold A, Shepherd FA, Ellis PM, Chen E, Goss G, Powers J, Walsh W, Tu D, Robertson J, Puchalski TA, Seymour L. Laurie SA, et al. J Clin Oncol. 2008 Apr 10;26(11):1871-8. doi: 10.1200/JCO.2007.14.4741. J Clin Oncol. 2008. PMID: 18398152 Clinical Trial.
20 results